Pubblicazioni

Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease

2020 - THE ONCOLOGIST
Ali, S.; Moreau, A.; Melchiorri, D.; Camarero, J.; Josephson, F.; Olimpier, O.; Bergh, J.; Karres, D.; Tzogani, K.; Gisselbrecht, C.; Pignatti, F.

National Italian Delphi panel consensus: Which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?

2020 - BMC CANCER
Lussana, F.; Minetto, P.; Ferrara, F.; Chiaretti, S.; Specchia, G.; Bassan, R.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma